Dose–response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial

Breast Cancer Research and Treatment

Volumn 154, Issue 2, 2015, Pages 309-318

  Schmitz, Kathryn H ^a   Williams, Nancy I ^b   Kontos, Despina ^a   Domchek, Susan ^a   Morales, Knashawn H ^a   Hwang, Wei Ting ^a   Grant, Lorita L ^a   DiGiovanni, Laura ^a   Salvatore, Domenick ^a   Fenderson, Desire’ ^a   Schnall, Mitchell ^a   Galantino, Mary Lou ^a   Stopfer, Jill ^a   Kurzer, Mindy S ^c   Wu, Shandong ^d   Adelman, Jessica ^a   Brown, Justin C ^a   Good, Jerene ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Breast MRI; Clinical trial; Estrogens; Exercise

Indexed keywords

ESTROGEN; PROGESTERONE; BIOLOGICAL MARKER;

ADULT; AEROBIC EXERCISE; AREA UNDER THE CURVE; ARTICLE; BACKGROUND PARENCHYMAL ENHANCEMENT; BODY MASS; BREAST CANCER; CANCER RISK; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIGITAL IMAGING; ESTROGEN URINE LEVEL; FEMALE; FOLLICULAR PHASE; FOLLOW UP; GENE MUTATION; HIGH RISK POPULATION; HUMAN; IMAGING AND DISPLAY; LUTEAL PHASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; CLINICAL TRIAL; EXERCISE; RISK ASSESSMENT; RISK FACTOR; URINE;

ADULT; BIOMARKERS; BREAST NEOPLASMS; ESTROGENS; EXERCISE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PREMENOPAUSE; PROGESTERONE; RISK ASSESSMENT; RISK FACTORS;

EID: 84947488182     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3604-z     Document Type: Article

References (45)

1. Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA (2002) Prophylactic bilateral mastectomy: patterns of practice. Cancer 95(2):236–242
2. Wainberg S, Husted J (2004) Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiol Biomarkers Prev 13(12):1989–1995
3. Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L et al (2006) Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Cancer 107(12):2745–2751
4. Narod SA (2006) Modifiers of risk of hereditary breast cancer. Oncogene 25(43):5832–5836
5. Eccles DM (2004) Hereditary cancer: guidelines in clinical practice. Breast and ovarian cancer genetics. Ann Oncol 15(Suppl 4:iv):133–138
6. Cooper BT, Murphy JO, Sacchini V, Formenti SC (2013) Local approaches to hereditary breast cancer. Ann Oncol 24(Suppl 8):viii54–viii60
7. King MC, Marks JH, Mandell JB (2003) New York Breast Cancer Study G: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646
8. Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD et al (2005) Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 7(5):R833–843
9. Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL et al (2006) The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis 27(3):599–605
10. Genuth SM (1993) The endocrine system. In: Berne RM, Levy MN (eds) Physiology, 3rd edn. Mosby Year Book, Philadelphia, pp 813–1024
11. Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O’Malley BW, Lydon JP (2003) Progesterone involvement in breast development and tumorigenesis—as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids 68(10–13):779–787
12. Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, Sieri S, Pala V, Berrino F (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112(2):312–318
13. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97(10):755–765
14. Kossman DA, Williams NI, Domchek SM, Kurzer MS, Stopfer JE, Schmitz KH (2011) Exercise lowers estrogen and progesterone levels in premenopausal women at high risk of breast cancer. J Appl Physiol 111(6):1687–1693
15. Smith AJ, Phipps WR, Arikawa AY, O’Dougherty M, Kaufman B, Thomas W, Schmitz KH, Kurzer MS (2011) Effects of aerobic exercise on premenopausal sex hormone levels: results of the WISER study, a randomized clinical trial in healthy, sedentary, eumenorrheic women. Cancer Epidemiol Biomarkers Prev 20(6):1098–1106
16. King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA (2011) Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology 260(1):50–60
17. Price ER, Brooks JD, Watson EJ, Brennan SB, Comen EA, Morris EA (2014) The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue. Eur Radiol 24(1):162–168
18. Pike MC, Pearce CL (2013) Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Ann Oncol 24(Suppl 8):viii37–viii41
19. King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA (2012) Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol 22(12):2641–2647
20. DeLeo MDS, Kontos D, Conant E, Chen J, Weinstein S (2015) Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingooophorectomy. Am J Roentgenol 3:669–673
21. Weinstein S, Rosen M (2010) Breast MR imaging: current indications and advanced imaging techniques. Radiol Clin North Am 48(5):1013–1042
22. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P et al (2003) The cancer genetics network: recruitment results and pilot studies. Community Genet 6(3):171–177
23. Claus EB, Risch N, Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73(3):643–651
24. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886
25. Howlader N, Noone NA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2014) SEER cancer statistics review, 1975-2011. National Cancer Institute, Bethesda
26. Stice E, Telch CF, Rizvi SL (2000) Development and validation of the Eating Disorder Diagnostic Scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder. Psychol Assess 12(2):123–131
27. Schmitz KH, Williams NI, Kontos D, Kurzer MS, Schnall M, Domchek S, Stopfer J, Galantino ML, Hwang WT, Morales K et al (2015) Women In Steady Exercise Research (WISER) Sister: study design and methods. Contemp Clin Trials 41C:17–30
28. Bruce RA, Kusumi F, Hosmer D (1973) Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85(4):546–562
29. Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, Bennett PH, Kuller LH (1990) Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 13(4):401–411
30. Munro C, Stbenfeldt G, Cragun J, Addiego L, Overstreet J, Lasley B (1991) Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their majority urinary metabolites as measured by enzyme immunoassay and radioassay. Clin Chem 37:838–844
31. Beitins IZ, McArthur JW, Turnbull BA, Skrinar GS, Bullen BA (1991) Exercise induces two types of human luteal dysfunction: confirmation by urinary free progesterone. J Clin Endocrinol Metab 72(6):1350–1358
32. Williams NI, Reed JL, Leidy HJ, Legro RS, De Souza MJ (2010) Estrogen and progesterone exposure is reduced in response to energy deficiency in women aged 25–40 years. Hum Reprod 25(9):2328–2339
33. Boston RC, Schnall MD, Englander SA, Landis JR, Moate PJ (2005) Estimation of the content of fat and parenchyma in breast tissue using MRI T1 histograms and phantoms. Magn Reson Imaging 23(4):591–599
34. Schmitz KH, Williams NI, Kontos D, Kurzer M, Schnall M, Domchek S, Stopfer J, Galantino ML, Hwang W, Morales K et al (2015) Women In Steady Exercise Research (WISER) Sister: study design and methods. Contemp Clin Trials 41:17–30
35. Wu S, Weinstein SP, Conant EF, Schnall MD, Kontos D (2013) Automated chest wall line detection for whole-breast segmentation in sagittal breast MR images. Med Phys 40(4):042301
36. Wu S, Weinstein SP, Conant EF, Kontos D (2013) Fully-automated fibroglandular tissue segmentation and volumetric density estimation in breast MRI by integrating a continuous max-flow model and a likelihood atlas. In: Novak C, Aylward S (eds) SPIE medical imaging: computer aided diagnosis, vol. 8670. Orlando, FL: 86701C
37. Wu S, Weinstein S, Kontos D (2012) Atlas-based probabilistic fibroglandular tissue segmentation in breast MRI. Med Image Comput Comput Assist Interv 15(Pt 2):437–445
38. Wu S, Weinstein SP, Conant EF, Kontos D (2013) Quantitative background parenchynal enhancement estimation on breast DCE-MRI by measuring relative voxel-wise enhancement. In: International Society for Magnetic Resonance in Medicine Annual Meeting. Salt Lake City, UT
39. Cohen J (1992) Statistical power analysis in the behavioral sciences, 2nd edn. Lawrence Erlbaum, Hillsdale
40. Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS (2013) The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 22(5):756–764
41. Matthews CE, Fortner RT, Xu X, Hankinson SE, Eliassen AH, Ziegler RG (2012) Association between physical activity and urinary estrogens and estrogen metabolites in premenopausal women. J Clin Endocrinol Metabol 97(10):3724–3733
42. Williams NI, Helmreich DL, Parfitt DB, Caston-Balderrama A, Cameron JL (2001) Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 86(11):5184–5193
43. Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, Willett WC, Hankinson SE, Ziegler RG (2012) Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 72(3):696–706
44. Melsaether A, McDermott M, Gupta D, Pysarenko K, Shaylor SD, Moy L (2014) Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training. AJR Am J Roentgenol 203(1):209–215
45. Monninkhof EM, Elias SG, Vlems FA, van der Tweel I, Schuit AJ, Voskuil DW, van Leeuwen FE (2007) Physical activity and breast cancer: a systematic review. Epidemiology 18(1):137–157